StemSight
StemSight cures severe corneal blindness with an off-the-shelf stem cell therapy - new treatments for blindness by differentiating cell therapies from human pluripotent stem cells.
StemSight has raised €2.8M across 2 funding rounds from 6 investors, most recently a round in Feb 2025. Based in Tampere, Finland; active in Healthtech. Data as of 28 Oct 2026.
Tampere, Finlandwww.stemsight.fi ↗
Total raised
€2.8M
€2,800,000
Funding rounds
2
Investors
6
distinct backers
Active since
2021-09
latest 2025-02
Funding by year
EUR raised per yearStemSight — funding by year — interactive chart.
Data table
| StemSight — funding by year | |
|---|---|
| 2021 | €500k |
| 2025 | €2.3M |
Signals
High confidenceRaise-next likelihood40
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-13 | Other | €2.3M | Biothom Oy,Business Finland,Private Investors,Stephen Industries,Voima Ventures | View deal → |
| 2021-09-13 | Pre-Seed | €500k | Avohoidon Tutkimussäätiö,Voima Ventures | View deal → |
Investors
6Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData